Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma

Clinical Radiology

Volumn 65, Issue 5, 2010, Pages 358-365

  Kim, Y K ^a   Kim, C S ^a   Han, Y M ^a   Park, G ^a   Hwang, S B ^a   Yu, H C ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FERUCARBOTRAN; GADOXETIC ACID; SHU 555; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; FERROSOFERRIC OXIDE; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77950340630     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2009.11.012     Document Type: Article

References (23)

1. Jeong Y.Y., Mitchell D.G., and Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178 (2002) 1327-1334
2. Holland A.E., Hecht E.M., Hahn W.Y., et al. Importance of small (≤20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237 (2005) 938-944
3. Kim Y.K., Lee Y.H., Kwak H.S., et al. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis. Clin Imaging 32 (2008) 453-459
4. Kim M.J., Kim J.H., Chung J.J., et al. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology 228 (2003) 719-726
5. Ward J., Guthrie J.A., Scott D.J., et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 216 (2000) 154-162
6. Kim Y.K., Kwak H.S., Han Y.M., et al. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography. J Comput Assist Tomogr 31 (2007) 702-711
7. Jung G., Breuer J., Poll L.W., et al. Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 47 (2006) 15-23
8. Tanimoto A., Satoh Y., Yuasa Y., et al. Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: a comparative study by alternative free-response receiver operating characteristic analysis. J Magn Reson Imaging 7 (1997) 120-124
9. Vogl T.J., Kummel S., Hammerstingl R., et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200 (1996) 59-67
10. Halavaara J., Breuer J., Ayuso C., et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT-a multicenter trial. J Comput Assist Tomogr 30 (2006) 345-354
11. Huppertz A., Haraida S., Kraus A., et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations. Radiology 234 (2005) 468-478
12. Ward J., and Robinson P.J. How to detect hepatocellular carcinoma in cirrhosis. Eur Radiol 12 (2002) 2258-2272
13. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the esophagus for bleeding esophageal varices. Br J Surg 60 (1973) 646-649
14. Edmondson H.A., and Steiner P.E. Primary carcinoma of liver: study of 100 cases among 48,900 necropsies. Cancer 7 (1954) 462-503
15. Lencioni R., Pinto F., Armillotta N., et al. Intrahepatic metastatic nodules of hepatocellular carcinoma detected at Lipiodol CT: imaging-pathologic correlation. Abdom Imaging 22 (1997) 253-258
16. Chakraborty D.P., and Winter L.H. Free-response methodology: alternate analysis and a new observer-performance experiment. Radiology 74 (1990) 873-881
17. Metz C.E. ROC methodology in radiologic imaging. Invest Radiol 21 (1986) 720-733
18. Rao J.N., and Scott A.J. A simple method for the analysis of clustered binary data. Biometrics 48 (1992) 577-585
19. Tanaka M., Nakashima O., Wada Y., et al. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 24 (1996) 807-812
20. Kim Y.K., Lee Y.H., Kwak H.S., et al. Small malignant hepatic tumor detection in gadolinium- and ferucarbotran-enhanced magnetic resonance imaging: does combining ferucarbotran-enhanced T2*-weighted gradient echo and T2-weighted turbo spin echo images have additive efficacy?. Korean J Radiol 9 (2008) 510-519
21. Kim Y.K., Kim C.S., Lee Y.H., et al. Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas. AJR Am J Roentgenol 182 (2004) 1217-1223
22. Bartolozzi C., Crocetti L., Lencioni R., et al. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 17 (2007) 2519-2530
23. Bruix J., Sherman M., Practice Guidelines Committee, and American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236